Registry of patients with coronary artery issues and platelet test results

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Onassist Project is a registry that collects data from patients with coronary artery disease who have undergone functional testing to measure the effectiveness of antiplatelet medications and/or have had their genetic response to these drugs assessed. This project aims to evaluate individual risks of stent thrombosis by combining functional and pharmacogenomic approaches. By identifying adverse drug interactions and treatment compliance issues, the registry provides tailored therapeutic recommendations to optimize drug choice and dosage. Regular follow-ups are conducted to monitor for major adverse cardiac events or bleeding complications.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* coronary disease
* antiplatelets testing performed as part of usual care and / or gentic profile of antiplatelet response done

Exclusion Criteria:

* patient refusing to be part of the registry

Where it's running

• Hopital Pitie Salpetriere
  Paris, France Recruiting

Study contacts

• Study coordinator: Jean Philippe COLLET, MD, PhD
• Email: jean-philippe.collet@aphp.fr
• Phone: +33142162962

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Investigating risk factors in patients with acute coronary syndrome undergoing a procedure

  This study is trying to find out what risk factors affect patients with acute coronary syndrome who are having a heart procedure and how these factors relate to their health outcomes over two years.

  Recruiting Jinan Central Hospital · Jinan, Shandong · NCT05719545

• Registry collecting data on patients undergoing heart artery procedures

  This study is collecting information from patients who are having heart artery procedures to see how they do during and after their treatment.

  Recruiting Federico II University · Naples · NCT05248165

• Comparing a new medication to standard treatment for preventing stomach issues in heart patients on blood thinners

  This study is testing a new medication called tegoprazan to see if it can prevent stomach problems just as well as the standard treatment for heart patients who are taking blood thinners.

  Recruiting at 36 sites Phase 4 Asan Medical Center · Anyang and 44 other locations · NCT04416581

• Registry for patients undergoing angioplasty in Korea

  This study is collecting information from patients who have had angioplasty to help understand how well the treatment works in real life.

  Recruiting Yonsei University · Seoul · NCT03908463

• See if stopping long-term aspirin is as good as continuing it in older adults with stable ischemic heart disease

  In adults 65 and older with stable ischemic heart disease, this trial tests whether stopping daily low-dose aspirin is not worse than continuing it.

  Recruiting at 2 sites Phase 4 Odense University Hospital · Copenhagen and 1 other locations · NCT07795398

• Registry for patients with kidney disease and heart issues

  This study collects information from adults with kidney disease and heart problems to see how their treatments and outcomes differ, helping us understand their health better.

  Recruiting Queen Mary University of London · London · NCT06521801

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.